Literature DB >> 7433566

The bioavailability of oral and parenteral chlorimipramine (Anafranil).

L E Evans, J H Bett, J R Cox, J P Dubois, T Van Hees.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7433566     DOI： 10.1016/0364-7722(80)90050-8

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol        ISSN： 0364-7722


× No keyword cloud information.
  7 in total

1.  [Expanding therapeutic reference ranges using dose-related reference ranges].

Authors:  E Haen; C Greiner; W Bader; M Wittmann
Journal:  Nervenarzt       Date:  2008-05       Impact factor: 1.214

2.  Computational models to assign biopharmaceutics drug disposition classification from molecular structure.

Authors:  Akash Khandelwal; Praveen M Bahadduri; Cheng Chang; James E Polli; Peter W Swaan; Sean Ekins
Journal:  Pharm Res       Date:  2007-09-11       Impact factor: 4.200

3.  Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data.

Authors:  M Gex-Fabry; A E Balant-Gorgia; L P Balant; G Garrone
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

Review 4.  Pharmacokinetic optimisation of tricyclic antidepressant therapy.

Authors:  M Furlanut; P Benetello; E Spina
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of clomipramine.

Authors:  A E Balant-Gorgia; M Gex-Fabry; L P Balant
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

Review 6.  Therapeutic approaches to the treatment of refractory obsessive-compulsive disorder.

Authors:  L D Kochan; A I Qureshi; B A Fallon
Journal:  Curr Psychiatry Rep       Date:  2000-08       Impact factor: 5.285

7.  A neonatal prolonged QT syndrome due to maternal use of oral tricyclic antidepressants.

Authors:  Naoya Fukushima; Kenji Nanao; Hiroyuki Fukushima; Akira Namera; Masaru Miura
Journal:  Eur J Pediatr       Date:  2016-04-12       Impact factor: 3.183
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.